Log in to search using one of your social media accounts:

 

FDA Approves Denosumab for Steroid-Induced Osteoporosis FDA Approves Denosumab for Steroid-Induced Osteoporosis
The US FDA has approved denosumab (Prolia, Amgen) for treatment of glucocorticoid-induced osteoporosis. European regulators recently green-lighted the same indication.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news

FDA Approves Prolia ® (Denosumab) For Glucocorticoid-Induced Osteoporosis
Fifth Indication for Prolia for Men and Women at High Risk of Fracture Receiving Systemic Glucocorticoid Therapy THOUSAND OAKS, Calif., May 21, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of Prolia® (denosumab) for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. This approval is based on data...
Source: Amgen News Release - May 21, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Effect of a balance-training programme on postural balance, aerobic capacity and frequency of falls in women with osteoporosis: a randomized controlled trial - Miko I, Szerb I, Szerb A, Bender T, Poor G.
OBJECTIVE: To investigate the effect of a 12-month complex balance-training programme on static and dynamic postural balance, aerobic capacity and frequency of falls in women with established osteoporosis. DESIGN: Randomized controlled trial in whi... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Effect of balance training on the falling in osteoporosis patients: a systematic review and meta-analysis - Zhou X, Ding H, Shen X, Lei Z.
BACKGROUND: Balance training may be beneficial for patients with osteoporosis, although current results are inconclusive. The aim of this systematic review and meta-analysis was to explore the effect of balance training on falls in patients with osteoporos... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Medical News Today: What happens when calcium levels are low?
We describe these issues in detail and explore symptoms and when to seek treatment. Learn more about calcium deficiency disease here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 21, 2018 Category: Consumer Health News Tags: Osteoporosis Source Type: news

Anxiety weakens your bones by cutting vitamin D and boosting cortisol
For the first time, an Italian study has revealed a link between higher anxiety levels and greater risks of brittle, fragile bones in postmenopausal women who are at greater risks for osteoporosis. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2018 Category: Consumer Health News Source Type: news

Alendronate Reduces Cardiovascular Risk After Hip Fracture Alendronate Reduces Cardiovascular Risk After Hip Fracture
Alendronate, and likely other bisphosphonates, lower cardiovascular event rates in patients treated for osteoporosis following a hip fracture.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 18, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Anxiety Might Get Into Women's Bones
The researchers noted that osteoporosis is the most common metabolic bone disease in the world. An estimated 33 percent of women and 20 percent of men will suffer from an osteoporosis-related fracture at some point in their lives. (Source: WebMD Health)
Source: WebMD Health - May 18, 2018 Category: Consumer Health News Source Type: news

Novel Agent Holds Promise for Treating Hair Loss Novel Agent Holds Promise for Treating Hair Loss
WAY-316606, a compound originally developed to treat osteoporosis, may one day help reverse hair loss in people with androgenetic alopecia, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 16, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Expert consensus finds that higher protein intake benefits adult bone health
(International Osteoporosis Foundation) A new expert consensus endorsed by the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) has reviewed the benefits and safety of dietary protein for bone health, based on analyses of major research studies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 15, 2018 Category: Biology Source Type: news

Fracture Risk During Bisphosphonate Drug Holiday Is a Concern Fracture Risk During Bisphosphonate Drug Holiday Is a Concern
Risks for fracture after suspension of bisphosphonates for osteoporosis need to be weighed against benefits, the authors say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 14, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Fall risk assessment metrics for elderly patients with hip fractures - Vottis CT, Mitsiokapa E, Igoumenou VG, Megaloikonomos PD, Galanopoulos IP, Georgoudis G, Koulouvaris P, Papagelopoulos PJ, Mavrogenis AF.
The most common surgery performed by orthopedic surgeons likely involves that for hip fractures. The incidence of hip fractures is anticipated to rise in the coming decades. Hip fractures most commonly occur in elderly women with osteoporosis after a fall ... (Source: SafetyLit)
Source: SafetyLit - May 11, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Bone Drug 'Holiday' May Raise Fracture Risk
Bisphosphonates, such as alendronate (Fosamax) and risedronate (Actonel), are the most widely prescribed osteoporosis drugs. They are designed to slow or prevent bone loss. (Source: WebMD Health)
Source: WebMD Health - May 11, 2018 Category: Consumer Health News Source Type: news

Osteoporosis Spinal Fractures; Vaginal Estradiol Tx; Diabetic Dog Lawsuit?
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - May 11, 2018 Category: OBGYN Source Type: news

Bone Drug'Holiday' From Bisphosphonates May Raise Fracture Risk
FRIDAY, May 11, 2018 -- Osteoporosis patients who take " holidays " from bisphosphonate drugs are at increased risk for fractures, a new study finds. A six-year follow-up of patients who took a break from the bone-building drugs found 15 percent of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 11, 2018 Category: General Medicine Source Type: news

Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday
FRIDAY, May 11, 2018 -- For patients with osteopenia or osteoporosis, taking a bisphosphonate (BP) drug holiday is associated with increased risk of fracture for patients with lower femoral neck bone mineral density (BMD) or T scores, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 11, 2018 Category: Pharmaceuticals Source Type: news

Osteoporosis drug may benefit heart health
(Wiley) The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2018 Category: International Medicine & Public Health Source Type: news

Surgery for osteoporosis ‘no better for pain relief than injections’
Surgery to repair spinal fractures is no more effective for pain relief than a sham procedure in older patients with osteoporosis, according to researchers in the Netherlands and the US. (Source: Nursing Times)
Source: Nursing Times - May 10, 2018 Category: Nursing Source Type: news

More Doubt Cast on Surgery for Spinal Compression Fractures
THURSDAY, May 10, 2018 -- In a new study, a widely used form of spinal surgery was no more effective than placebo in treating spinal fracture pain for people with osteoporosis. Researchers and experts now say that the technique -- called... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 10, 2018 Category: General Medicine Source Type: news

Depression Has Spiked By 33% In the Last Five Years, a New Report Says
Diagnoses of clinical depression — also known as major depression — have risen by 33% since 2013, according to a new report from health insurer Blue Cross Blue Shield. The report, which was based on insurance claims filed by 41 million privately insured Blue Cross Blue Shield members, calls depression the “second most impactful condition on overall health for commercially insured Americans,” behind only high blood pressure. That’s because people with depression also tend to have other health issues, such as chronic illnesses and substance abuse, and as a result may have more significant health...
Source: TIME: Health - May 10, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime Mental Health/Psychology onetime Source Type: news

They can keep their ‘cure’ for baldness. I love my hairless head | Tom Usher
When I started losing my long, obsidian, Linkin Park hair, I shaved it all off. It ’s one of the best decisions I’ve ever madeIn news that will be mostly of no use to anyone but ennui-ridden middle-aged men now contemplating their lost youth in the wake of their own fading good looks, it looks like apotential cure for baldness has been found. Scientists from the University of Manchester used a drug originally intended to treat osteoporosis on samples containing scalp hair follicles from more than 40 male hair-transplant patients, and found that the drug had a impressive effect on hair follicles, reviving their ...
Source: Guardian Unlimited Science - May 10, 2018 Category: Science Authors: Tom Usher Tags: Men's hair Beauty Life and style Fashion Health & wellbeing UK news Ageing Science Source Type: news

This Osteoporosis Drug Has a Surprising Side-Effect. Scientists Say It Could Cure Baldness
Researchers may have discovered a new cure for baldness using a drug initially intended to treat osteoporosis. Scientists from the University of Manchester say the drug,WAY-316606, stimulated hair growth in the lab by targeting a protein that halts hair growth and contributes to baldness, BBC reports. They were originally testing Cyclosporine A, an immunosuppressive drug that has been used since the 1980s to stop rejections in organ transplants and mitigate symptoms of autoimmune diseases. While it was found to suppress hair loss, Cyclosporine A had side-effects that made it unsuitable. So the team went on looking for a dr...
Source: TIME: Health - May 10, 2018 Category: Consumer Health News Authors: Casey Quackenbush Tags: Uncategorized onetime overnight Research Source Type: news

Side effects include ... a potential treatment for baldness
Though it's normal to lose up to 100 hairs from your scalp every day, excessive hair loss is distressing. But a drug originally developed to treat osteoporosis may soon help those who want to treat or even reverse baldness, according to research published Tuesday in the journal PLOS Biology. (Source: CNN.com - Health)
Source: CNN.com - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Drug trial discovers potential treatment for baldness
Though it's normal to lose up to 100 hairs from your scalp every day, excessive hair loss is distressing. But a drug originally developed to treat osteoporosis may soon help those who want to treat or even reverse baldness, according to research published Tuesday in the journal PLOS Biology. (Source: CNN.com - Health)
Source: CNN.com - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Could experimental drug lead to treatment for baldness?
A novel approach to treating hair loss looks at a drug originally intended for osteoporosis (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 9, 2018 Category: Consumer Health News Source Type: news

WATCH: Drug could hold cure for baldness
British researchers claim that a drug used to treat osteoporosis could also help stop hair loss. (Source: ABC News: Health)
Source: ABC News: Health - May 9, 2018 Category: Consumer Health News Tags: Health Source Type: news

Medical News Today: Existing drug may be the answer to hair loss
Treating hair loss is an ongoing challenge for researchers. A recent paper concludes that an osteoporosis drug may just hold the secret. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 9, 2018 Category: Consumer Health News Tags: Dermatology Source Type: news

Drug designed to treat osteoporosis could be a cure for baldness
The osteoporosis drug, discovered to work for baldness by the University of Manchester, targets a protein that acts as a brake on hair growth and plays a key role in hair loss. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

A Bone Drug That Treats Baldness?
TUESDAY, May 8, 2018 -- A drug intended as a treatment for osteoporosis may help treat hair loss, researchers say. " The fact this new agent, which had never even been considered in a hair loss context, promotes human hair growth is exciting because... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 8, 2018 Category: General Medicine Source Type: news

Medical News Today: Common drug may help battle aggressive breast cancer
A new study concludes that a common osteoporosis drug may help to fight basal-like breast cancer, which is an aggressive, early-onset form of the disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 5, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Screen All Men Age 85 and Older for Osteoporosis Screen All Men Age 85 and Older for Osteoporosis
Clinical practice guidelines are clear on when women should be screened for osteoporosis, but not when men should be tested, so a new study assessed the timing.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

MicroRNA Changes in Response to Osteoporosis Treatment MicroRNA Changes in Response to Osteoporosis Treatment
How are circulating microRNAs affected by treatment with these two antiosteoporotic drugs?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Osteoporosis drug could be used to treat aggressive form of breast cancer, researchers say
(Rockefeller University Press) Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer, an aggressive form of the disease that is largely untreatable. But the study, which will be published May 4 in the Journal of Experimental Medicine, reveals that the widely used osteoporosis drug zoledronic acid inhibits UGT8 and prevents the spread of basal-like breast cancer in mice, suggesting that this drug could also be used to treat the disease in humans. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 4, 2018 Category: Cancer & Oncology Source Type: news

Fifteen percent of osteoporosis patients who take 'drug holidays' suffer bone fractures
(Loyola University Health System) A Loyola Medicine study has found that 15.4 percent of patients who take so-called 'drug holidays' from osteoporosis drugs called bisphosphonates experienced bone fractures. During a six-year follow-up period, the yearly incidence of fractures ranged from 3.7 percent to 9.9 percent, with the most fractures occurring during the fourth and fifth years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 4, 2018 Category: International Medicine & Public Health Source Type: news

Tackling the challenges of living with multiple health conditions
We know that many people with arthritis also live with other conditions– this is known as‘multimorbidity’. Living with many conditions can have a huge impact on individuals: there can be more medication and medical appointments to manage, or one condition could impact on a person’s ability to manage another. It also has a knock-on effect on health and care, for example a ten-minute consultation with a GP may not be enough time to discuss the impact of many conditions. We believe it is one of the largest and most complex challenges facing our health and care systems today.Our policy and campaigns tea...
Source: Arthritis Research UK - May 2, 2018 Category: Rheumatology Source Type: news

UAB-led study shows promise for bone density drug
An alternative treatment for people taking glucocorticoids shows promise through a UAB-led study.   Long-term use of these drugs, which includes prednisone, causes osteoporosis, which results in a yearly bone fracture rate of 5 percent.  A UAB-led international study published in “The Lancet Diabetes& Endocrinology ” medical journal, and headed by Kenneth Saag, professor of medicine at UAB, indicates alternative drugs can be effective. The study was funded by Amgen which markets denosumab… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 30, 2018 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Treats Bone Loss in Patients Using Glucocorticoid Medications who are at Increased Risk of Fracture THOUSAND OAKS, Calif., April 27, 2018 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal... Biopharmaceuticals, Regulatory Amgen, Prolia, denosumab, Glucocorticoid-Induced, Osteoporosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 27, 2018 Category: Pharmaceuticals Source Type: news

Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia ® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Treats Bone Loss in Patients Using Glucocorticoid Medications who are at Increased Risk of Fracture THOUSAND OAKS, Calif., April 27, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of Prolia® (denosumab) for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture. "Today's positive opinion by the CHMP is an important step for Prolia in help...
Source: Amgen News Release - April 27, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

ESCEO-IOF Pierre Meunier Young Scientist Award presented to Dr. Emmanuel Biver
(International Osteoporosis Foundation) Dr. Emmanuel Biver of the Division of Bone Diseases Geneva University Hospitals and Faculty of Medicine has been presented with the 2018 ESCEO-IOF Pierre Meunier Young Scientist Award. The joint award of the European Society for Clinical& Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) was awarded on April 22nd, at the World Congress on Osteoporosis, Osteoarthritis& Musculoskeletal Diseases, held in Krak ó w, Poland. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2018 Category: International Medicine & Public Health Source Type: news

State-of-the-art reviews in osteoimmunology
(International Osteoporosis Foundation) A series of outstanding, well illustrated reviews by leading experts in osteoimmunology provide new insights and point to future directions in one of the most rapidly evolving areas of research within the bone field. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2018 Category: International Medicine & Public Health Source Type: news

Prevention and treatment of osteoporosis using Chinese medicinal plants: special emphasis on mechanisms of immune modulation - Zhao H, Zhao N, Zheng P, Xu X, Liu M, Luo D, Xu H, Ju D.
Numerous studies have examined the pathogenesis of osteoporosis. The causes of osteoporosis include endocrine factors, nutritional status, genetic factors, physical factors, and immune factors. Recent osteoimmunology studies demonstrated that the immune sy... (Source: SafetyLit)
Source: SafetyLit - April 23, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Mayo Clinic Minute: Exercise helps prevent bone fractures and falls
Vitamin D supplements no longer are recommended to prevent falls for people 65 years or older, according to new guidelines by the?U.S. Preventative Services Task Force (USPSTF).?Instead, the emphasis is on exercise. The new recommendations do not apply to people with increased risk for falls or a diagnosis of?osteoporosis. Dr. Robert Wermers, an endocrinologist at [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 23, 2018 Category: Databases & Libraries Source Type: news

Interactive map reveals millions of people aren't eating enough calcium
Nepal in Asia was found to be the worst offender - having an intake of calcium seven times lower than the amount in Iceland, according to The International Osteoporosis Foundation. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2018 Category: Consumer Health News Source Type: news

Map reveals millions of people aren't eating enough calcium
Nepal in Asia was found to be the worst offender - having an intake of calcium seven times lower than the amount in Iceland, according to The International Osteoporosis Foundation. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2018 Category: Consumer Health News Source Type: news

In many countries, bone health may be at risk due to low calcium intake
(International Osteoporosis Foundation) At a special symposium held today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Krakow, Poland, experts discussed the findings of the newly launched IOF Global Map of Dietary Calcium Intake in Adults and the implications of low calcium intake for the global population. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2018 Category: International Medicine & Public Health Source Type: news

Hans Peter Dimai named winner of 2018 IOF President's Award
(International Osteoporosis Foundation) Today at a ceremony held at the World Congress on Osteoporosis, Osteoarthritis& Musculoskeletal Diseases in Krakow, Professor Hans Peter Dimai, Professor of Medicine and Endocrinology at the Medical University of Graz, Austria, was presented with the prestigious IOF President's Award. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 20, 2018 Category: Biology Source Type: news

Focus on osteoporosis, osteoarthritis and sarcopenia at largest congress in the field
(International Osteoporosis Foundation) The International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) will welcome more than 4,000 delegates to the WCO-IOF-ESCEO 2018, opening today in Krak ó w, Poland. The CME-accredited Congress is the world's largest gathering of clinicians and researchers working in the field of musculoskeletal disorders. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 19, 2018 Category: Biology Source Type: news

Dental implants in patients with osteoporosis?
Whether Osteoporosis influences the long-term survival of dental implants, is still an unsettled issue.The postDental implants in patients with osteoporosis? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 16, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Implant News Source Type: news

NIH researchers crack mystery behind rare bone disorder
(NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases) Researchers at the National Institutes of Health worked with 15 patients from around the world to uncover a genetic basis of 'dripping candle wax' bone disease. The rare disorder, known as melorheostosis, causes excess bone formation that resembles dripping candle wax on x-rays. The results, appearing in Nature Communications, offer potential treatment targets for this rare disease, provide important clues about bone development, and may lead to insights about fracture healing and osteoporosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 11, 2018 Category: International Medicine & Public Health Source Type: news

Cheese and lasagne protect MEN from osteoporosis as they age
A study of 2,600 people found men over 50 who consumed cheese on its own or on a pizza had stronger spines and hips. Dairy did not do the same for women, apart from a small boost from cream. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2018 Category: Consumer Health News Source Type: news